688108.SS SHH
Sino Medical Sciences Technology Inc.
1W: -7.5%
1M: -11.0%
3M: -22.6%
YTD: -33.8%
1Y: -27.2%
3Y: +47.2%
5Y: +21.9%
¥14.87 ($2.22)
+0.22 (+1.50%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$1.3B
+3.8% ▲
5Y CAGR: +2.1%
Total Liabilities
-$932M
-331.7% ▼
Shareholders Equity
$932M
+7.5% ▲
5Y CAGR: -2.9%
Cash & Investments
$396M
+35.9% ▲
5Y CAGR: -6.2%
Total Debt
$130M
+2.1% ▲
5Y CAGR: +20.5%
Net Debt
-$267M
-61.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $288M | $203M | $189M | $292M | $396M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $288M | $203M | $189M | $292M | $396M |
| Net Receivables | $12M | $20M | $28M | $19M | $33M |
| Inventory | $85M | $98M | $118M | $90M | $0 |
| Other Current Assets | $16M | $30M | $9M | $3M | $91M |
| Total Current Assets | $431M | $355M | $344M | $403M | $520M |
| Property, Plant & Equip. | $173M | $177M | $166M | $136M | $0 |
| Goodwill & Intangibles | $314M | $355M | $378M | $629M | $631M |
| Long-Term Investments | $120M | $19M | $14M | $0 | $0 |
| Other Non-Current Assets | $21M | $71M | $178M | $21M | $198M |
| Total Non-Current Assets | $672M | $713M | $842M | $897M | $829M |
| Total Assets | $1.1B | $1.1B | $1.2B | $1.3B | $1.3B |
| — Liabilities — | |||||
| Accounts Payable | $23M | $28M | $20M | $21M | $33M |
| Short-Term Debt | $17M | $46M | $54M | $53M | $115M |
| Deferred Revenue | $52M | $791K | $0 | $0 | $0 |
| Other Current Liabilities | $52M | $57M | $78M | $18M | $186M |
| Total Current Liabilities | $93M | $132M | $151M | $192M | $334M |
| Long-Term Debt | $0 | $0 | $50M | $55M | $0 |
| Other Non-Current Liab. | $16M | $11M | $56M | $82M | -$932M |
| Total Non-Current Liabilities | $65M | $48M | $173M | $210M | -$932M |
| Total Liabilities | $158M | $180M | $324M | $402M | -$932M |
| — Equity — | |||||
| Common Stock | $410M | $410M | $410M | $413M | $416M |
| Retained Earnings | -$42M | -$195M | -$235M | -$233M | -$194M |
| Accumulated OCI | $44M | $47M | $2M | $52M | $901M |
| Total Stockholders Equity | $928M | $847M | $820M | $867M | $932M |
| Total Liabilities & Equity | $1.1B | $1.1B | $1.2B | $1.3B | $1.3B |
| — Key Metrics — | |||||
| Total Debt | $44M | $58M | $144M | $127M | $130M |
| Net Debt | -$243M | -$145M | -$44M | -$165M | -$267M |
| Total Investments | $120M | $19M | $14M | $0 | $0 |